Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors

Clinical trial NCT01836549 · TERMINATED

Trial details

NCT number: NCT01836549
Sponsor: Pediatric Brain Tumor Consortium
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Anaplastic Astrocytoma Anaplastic Ependymoma Astrocytoma, Grade II Ependymoma Giant Cell Glioblastoma Glioblastoma Gliosarcoma Oligodendroglioma Brainstem Tumors

Start date: 2013-03-01
Primary completion: 2016-04-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.